Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers

Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics10020065
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Therapeutic Applications of Curcumin Nanoformulations

AAPS Journal
Pharmaceutical Science
2015English

Copper Complex Nanoformulations Featuring Highly Promising Therapeutic Potential in Murine Melanoma Models

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2019English

Mouse ES Cells Express Endogenous shRNAs, siRNAs, and Other Microprocessor-Independent, Dicer-Dependent Small RNAs

Genes and Development
GeneticsDevelopmental Biology
2008English

Pharmacodynamics and Therapeutic Usage of Recombinant Human Erythropoietin (SNB-5001) in Animal Models.

Folia Pharmacologica Japonica
Pharmacology
1992English

Development of Novel Therapeutic Strategies in Cancers and Sarcomas

Juntendo Medical Journal
2017English

Proteomic Identification of Pathways Responsible for the Estradiol Therapeutic Window in AD Animal Models

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2019English

Cancer Therapeutic Targeting Using Mutant–p53-Specific siRNAs

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Therapeutic Potency of PI3K Pharmacological Inhibitors of Gastrointestinal Cancer

Middle East Journal of Digestive Diseases
HepatologyGastroenterology
2018English

Stargardt Disease: Clinical Features, Molecular Genetics, Animal Models and Therapeutic Options

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy